Effects of nociceptin/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: Comparison to morphine

European Journal of Pharmacology

Volumn 579, Issue 1-3, 2008, Pages 141-148

  Reiss, David ^a   Wichmann, Juergen ^b   Tekeshima, Hiroshi ^c   Kieffer, Brigitte L ^d   Ouagazzal, Abdel Mouttalib ^d  

^a INSTITUT CLINIQUE DE LA SOURIS   (France)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c KYOTO UNIVERSITY   (Japan)

^d INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

(Mice); Analgesia; mu receptor; Nociceptin; NOP receptor

Indexed keywords

8 (2,3,3A,4,5,6 HEXAHYDRO 1H PHENALEN 1 YL) 1 PHENYL 1,3,8 TRIAZASPIRO[4.5]DECAN 4 ONE; MORPHINE; MU OPIATE RECEPTOR AGONIST; NOCICEPTIN RECEPTOR AGONIST;

ANALGESIA; ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; KNOCKOUT MOUSE; MALE; MOUSE; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PRIORITY JOURNAL; SHOCK; STRESS; TAIL FLICK TEST; WILD TYPE;

ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HEAT; IMIDAZOLES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHINE; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; REACTION TIME; RECEPTORS, OPIOID; RECEPTORS, OPIOID, MU; SPIRO COMPOUNDS; STRESS; TAIL;

EID: 37549049435     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.10.031     Document Type: Article

References (51)

1. Chen L.X., Wang Z.Z., Wu H., Fang Q., Chen Y., and Wang R. Effects of nociceptin (13-17) in pain modulation at supraspinal level in mice. Neurosci. Lett. 331 (2002) 95-98
2. Chen X., Geller E.B., and Adler M.W. Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test. Eur. J. Pharmacol. 557 (2007) 32-36
3. Chiou L.C., Liao Y.Y., Kuo P.H., Wang C.H., Riemer C., and Prinssen E.P. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications. Curr. Drug Targets 8 (2007) 117-135
4. Ciccocioppo R., Biondini M., Antonelli L., Wichmann J., Jenck F., and Massi M. Reversal of stress-and CRF-induced anorexia in rats by the synthetic nociceptin/orphanin FQ receptor agonist, Ro 64-6198. Psychopharmacology 161 (2002) 113-119
5. Contet C., Gavériaux-Ruff C., Matifas A., Caradec C., Champy M.F., and Kieffer B.L. Dissociation of analgesic and hormonal responses to forced swim stress using opioid receptor knockout mice. Neuropsychopharmacology 31 (2006) 1733-1744
6. Darland T., Heinricher M.M., and Grandy D.K. Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more. Trends Neurosci. 21 (1998) 215-221
7. Dautzenberg F.M., Wichmann J., Higelin J., Py-Lang G., Kratzeinsen C., Malherbe P., Kilpatrick J.G., and Jenck F. Pharmacological characterization of the novel nonpetide orphanin FQ/nociceptin receptor agonist Ro64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo. J. Pharmacol Exp. Ther. 298 (2001) 812-819
8. Depner U.B., Reinscheid R.K., Takeshima H., Brune K., and Zeilhofer H.U. Normal sensitivity to acute pain, but increased inflammatory hyperalgesia in mice lacking the nociceptin precursor polypeptide or the nociceptin receptor. Eur. J. Neurosci. 1 (2003) 2381-2387
9. Gavioli E.C., Rae G.A., Calo G., Guerrini R., and De Lima T.C. Central injections of nocistatin or its C-terminal hexapeptide exert anxiogenic-like effect on behaviour of mice in the plus-maze test. Br. J. Pharmacol. 136 (2002) 764-772
10. Griebel G., Perrault G., and Sanger D.J. Orphanin FQ, a novel neuropeptide with anti-stress-like activity. Brain Res. 836 (1999) 221-224
11. Grisel J.E., and Mogil J.S. Effects of supraspinal orphanin FQ/nociceptin. Peptides 21 (2000) 1037-1045
12. Hawes B.E., Graziano M.P., and Lambert D.G. Cellular actions of nociceptin: transduction mechanisms. Neuropeptide 21 (2000) 961-967
13. Heinricher M.M. Nociceptin/orphanin FQ: pain, stress and neural circuits. Life Sci. 77 (2005) 3127-3132
14. Higgins G.A., Grottick A.J., Ballard T.M., Richards J.G., Messer J., Takeshima H., Pauly-Evers M., Jenck F., Adam G., and Wichmann J. Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function. Neuropharmacology 41 (2001) 97-107
15. Higgins G.A., Kew J.N., Richards J.G., Takeshima H., Jenck F., Adam G., Wichmann J., Kemp J.A., and Grottick A.J. A combined pharmacological and genetic approach to investigate the role of orphanin FQ in learning and memory. Eur. J. Neurosci. 15 (2002) 911-922
16. Jenck F., Moreau J.-L., Martin J.R., Kilpatrick G., Reinscheid R., Monsma F.J., Nothacker H.-P., and Civelli O. Orphanin FQ acts as anxiolytic to attenuate behavioral responses to stress. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4854-14858
17. Jenck F., Wichmann J., Dautzenberg F.M., Moreau J.-L., Ouagazzal A., Martin J., Lundstrom K., Cesura A., Poli S., Roever S., Kolczewski S., Adam G., and Kilpatrik G. A novel synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 4938-4943
18. Kamei J., Matsunawa Y., Miyata S., Tanaka S., and Saitoh A. Effects of nociceptin on the exploratory behavior of mice in the hole-board test. Eur. J. Pharmacol. 489 (2004) 77-87
19. Kotlinska J., Wichmann J., Rafalski P., Talarek S., Dylag T., and Silberring J. Non-peptidergic OP4 receptor agonist inhibits morphine antinociception but does not influence morphine dependence. Neuroreport 14 (2003) 601-604
20. Kyuhou S., and Gemba H. Injection of orphanin FQ/nociceptin into the periaqueductal gray suppresses the forebrain-elicited vocalization in the guinea pig. Neurosci. Lett. 260 (1999) 113-116
21. Le Bars D., Gozariu M., and Cadden S.W. Animal models of nociception. Pharmacol. Rev. 53 (2001) 597-652
22. Leventhal L., Mathis J.P., Rossi G.C., Pasternak G.W., and Bodnar R.J. Orphan opioid receptor antisense probes block orphanin FQ-induced hyperphagia. Eur. J. Pharmacol. 349 (1998) R1-R3
23. Manabe T., Noda Y., Mamiya T., Katagiri H., Houtani T., Nishi M., Noda T., Takahashi T., Sugimoto T., Nabeshima T., and Takeshima H. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature 394 (1998) 577-581
24. Meis S.Z. Nociceptin/Orphanin FQ: actions within the brain. Neuroscientist 9 (2003) 158-168
25. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., and Monsarrat B. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377 (1995) 532-535
26. Meziane H., Ouagazzal A.M., Aubert L., Wietrzych M., and Krezel W. Estrous cycle effects on behavior of C57BL/6J and BALB/cByJ female mice: implications for phenotyping strategies. Genes Brain Behav. 6 (2007) 192-200
27. Mogil J.S., and Pasternak G.W. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol. Rev. 53 (2001) 381-415
28. Mogil J.S., Sternberg W.F., Balian H., Liebeskind J.C., and Sadowski B. Opioid and nonopioid swim stress-induced analgesia: a parametric analysis in mice. Physiol. Behav. 59 (1996) 123-132
29. Nazzaro C., Rizzi A., Salvadori S., Guerrini R., Regoli D., Zeilhofer H.U., and Calo G. UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ: behavioral and electrophysiological studies in mice. Peptides 28 (2006) 663-669
30. Nazzaro C., Rizzi A., Salvadori S., Guerrini R., Regoli D., Zeilhofer H.U., and Calo G. UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ: behavioral and electrophysiological studies in mice. Peptides 28 (2007) 663-669
31. Neal Jr. C.R., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., and Watson Jr. S.J. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 406 (1999) 503-547
32. Neil A., and Terenius L. An improved foot-shock titration procedure in rats for centrally acting analgesics. Acta Pharmacol. Toxicol. (Copenh) 50 (1982) 93-99
33. New D.C., and Wong Y.H. The ORL1 receptor: molecular pharmacology and signalling mechanisms. Neurosignals 11 (2002) 197-212
34. Nicolas L.B., Kolb Y., and Prinssen E.P. A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants. Eur. J. Pharmacol. 547 (2007) 106-115
35. Nishi M., Houtani T., Noda Y., Mamiya T., Sato K., Doi T., Kuno J., Takeshima H., Nukada T., Nabeshima T., Yamashita T., Noda T., and Sugimoto T. Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphaninFQ receptor. EMBO J. 16 (2002) 1858-1864
36. Obara I., Przewlocki R., and Przewlocka B. Spinal and local peripheral antiallodynic activity of Ro64-6198 in neuropathic pain in the rat. Pain 116 (2005) 17-25
37. Ouagazzal A.M., Moreau J.-L., Pauly-Evers M., and Jenck F. Impact of environmental housing conditions on the emotional responses of mice deficient for nociceptin/orphanin FQ peptide precursor gene. Behav. Brain Res. 144 (2003) 111-117
38. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma Jr. F.J., and Civelli O. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science 270 (1995) 792-794
39. Richards J.G., Higgins G.A., Ouagazzal A.M., Ozmen L., Kew J.N., Bohrmann B., Malherbe P., Jacobsen H., Brockhaus M., Loetscher H., Czech C., Huber G., Bluethmann H., and Kemp J.A. Transgenic mice coexpressing hAPPswe and hPS2mut show age-related discrete brain amyloid deposition and inflammation associated with cognitive deficits. J. Neurosci. 23 (2003) 8989-9003
40. Rizzi A., Marzola G., Bigoni R., Guerrini R., Salvadori S., Mogil J.S., Regoli D., and Calo G. Endogenous nociceptin signaling and stress-induced analgesia. Neuroreport 12 (2001) 3009-3013
41. Rossi G.C., Leventhal L., Bolan E., and Pasternak G.W. Pharmacological characterization of orphanin FQ/nociceptin and its fragments. J. Pharmacol. Exp. Ther. 282 (1997) 858-865
42. Rossi G.C., Perlmutter M., Leventhal L., Talatti A., and Pasternak G.W. Orphanin FQ/nociceptin analgesia in the rat. Brain Res. 792 (1998) 327-330
43. Shane R., Lazar D.A., Rossi G.C., Pasternak G.W., and Bodnar R.J. Analgesia elicited by OFQ/nociceptin and its fragments from the amygdala in rats. Brain Res. 907 (2001) 109-116
44. Stanfa L.C., Chapman V., Kerr N., and Dickenson A.H. Inhibitory action of nociceptin on spinal dorsal horn neurones of the rat, in vivo. Br. J. Pharmacol. 118 (1996) 1875-1877
45. Suaudeau C., Florin S., Meunier J.C., and Costentin J. Nociceptin-induced apparent hyperalgesia in mice as a result of the prevention of opioid autoanalgesic mechanisms triggered by the stress of an intracerebroventricular injection. Fundam. Clin. Pharmacol. 12 (1998) 420-425
46. Swedberg M.D. The mouse grid-shock analgesia test: pharmacological characterization of latency to vocalization threshold as an index of antinociception. J. Pharmacol. Exp. Ther. 269 (1994) 1021-1028
47. Terman G.W., Morgan M.J., and Liebeskin J.C. Opioid and non-opioid stress analgesia from cold water swim: importance of stress severity. Brain Res. 372 (1986) 167-171
48. Vanderah T.W., Raffa R.B., Lashbrook J., Burritt A., Hruby V., and Porreca F. Orphanin-FQ/nociceptin: lack of anti nociceptive, hyperalgesic or allodynic effects in acute thermal or mechanical tests following intracerebroventricular or intrathecal administration to mice or rats. Eur. J. Pain 2 (1998) 267-278
49. Varty G.B., Hyde L.A., Hodgson R.A., Lu S.X., McCool M.F., Kazdoba T.M., Del Vecchio R.A., Guthrie D.H., Pond A.J., Grzelak M.E., Xu X., Korfmacher W.A., Tulshian D., Parker E.M., and Higgins G.A. Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species. Psychopharmacology (Berl) 182 (2005) 132-143
50. Wichmann J., Adam G., Rover S., Hennig M., Scalone M., Cesura A.M., and Jenck F. Synthesis of (1S,3aS)-8-(2,3,3a,4,5, 6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4. 5]decan-4-one, a potent and selective orphanin FQ (OFQ) receptor agonist with anxiolytic-like properties. Eur. J. Med. Chem. 35 (2000) 839-851
51. Zaveri N., Jiang F., Olsen C., Polgar W., and Toll L. Small-molecule agonists and antagonists of the opioid receptor-like receptor (ORL1, NOP): ligand-based analysis of structural factors influencing intrinsic activity at NOP. AAPS J. 72 (2005) E345-E352